The estimated Net Worth of Ii Anthony Zezzo is at least 928 千$ dollars as of 7 August 2017. Ii Zezzo owns over 72,916 units of Orasure Technologies stock worth over 927,886$ and over the last 14 years Ii sold OSUR stock worth over 0$.
Ii has made over 2 trades of the Orasure Technologies stock since 2017, according to the Form 4 filled with the SEC. Most recently Ii exercised 72,916 units of OSUR stock worth 416,350$ on 7 August 2017.
The largest trade Ii's ever made was exercising 115,000 units of Orasure Technologies stock on 10 May 2017 worth over 683,100$. On average, Ii trades about 10,440 units every 5 days since 2011. As of 7 August 2017 Ii still owns at least 218,326 units of Orasure Technologies stock.
You can see the complete history of Ii Zezzo stock trades at the bottom of the page.
Ii's mailing address filed with the SEC is 220 EAST FIRST STREET, , BETHLEHEM, PA, 18015.
Over the last 21 years, insiders at Orasure Technologies have traded over 21,897,384$ worth of Orasure Technologies stock and bought 196,200 units worth 1,037,188$ . The most active insiders traders include Douglas A Michels、Ronald H Spair、Michael J Gausling. On average, Orasure Technologies executives and independent directors trade stock every 43 days with the average trade being worth of 221,123$. The most recent stock trade was executed by Kathleen Gallagher Weber on 19 December 2023, trading 24,129 units of OSUR stock currently worth 194,238$.
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
Orasure Technologies executives and other stock owners filed with the SEC include: